Clinical spectrum of homozygous and heterozygous PINK1 mutations in a large german family with parkinson disease: Role of a single hit?

Archives of Neurology

Volumn 63, Issue 6, 2006, Pages 833-838

  Hedrich, Katja ^a   Hagenah, Johann ^a   Djarmati, Ana ^a,g   Hiller, Anja ^a   Lohnau, Thora ^a   Lasek, Kathrin ^a   Grünewald, Anne ^a   Hilker, Rüdiger ^b   Steinlechner, Susanne ^a   Boston, Heather ^a   Kock, Norman ^a   Schneider Gold, Christiane ^c   Kress, Wolfram ^f   Siebner, Hartwig ^d,h   Binkofski, Ferdinand ^a,h   Lencer, Rebekka ^a   Münchau, Alexander ^e   Klein, Christine ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

^d UNIVERSITY OF KIEL   (Germany)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^f UNIVERSITY OF WÜRZBURG   (Germany)

^g UNIVERSITY OF BELGRADE   (Serbia)

^h NeuroImage Nord ^*  (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

CABERGOLINE; LEVODOPA; SELEGILINE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE; GENE MUTATION; GENETIC ANALYSIS; GENOTYPE; GERMANY; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MEDICAL SPECIALIST; NEUROLOGIC EXAMINATION; NONSENSE MUTATION; PARKINSON DISEASE; PINK1 GENE; PRIORITY JOURNAL;

EID: 33745099053     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.63.6.833     Document Type: Article

References (25)

1. Valente EM, Abou-Sleiman PM, Caputo V, et al. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science. 2004;304:1158-1160.
2. Valente EM, Bentivoglio AR, Dixon PH, et al. Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36. Am J Hum Genet. 2001;68:895-900.
3. Hatano Y, Sato K, Elibol B, et al. PARK6-linked autosomal recessive early-onset parkinsonism in Asian populations. Neurology. 2004;63:1482-1485.
4. Hatano Y, Li Y, Sato K, et al. Novel PINK1 mutations in early-onset parkinsonism. Ann Neurol. 2004;56:424-427.
5. Khan NL, Valente EM, Bentivoglio AR, et al. Clinical and subclinical dopaminergic dysfunction in PARK6-linked parkinsonism: an 18F-dopa PET study. Ann Neurol. 2002;52:849-853.
6. Valente EM, Salvi S, Ialongo T, et al. PINK1 mutations are associated with sporadic early-onset parkinsonism. Ann Neurol. 2004;56:336-341.
7. Bonifati V, Rohe CF, Breedveld GJ, et al; Italian Parkinson Genetics Network. Early-onset parkinsonism associated with PINK1 mutations: frequency, genotypes, and phenotypes. Neurology. 2005;65:87-95.
8. Albanese A, Valente EM, Romito LM, Bellacchio E, Elia AE, Dallapiccola B. The PINK1 phenotype can be indistinguishable from idiopathic Parkinson disease. Neurology. 2005;64:1958-1960.
9. Rohe CF, Montagna P, Breedveld G, Cortelli P, Oostra BA, Bonifati V. Homozygous PINK1 C-terminus mutation causing early-onset parkinsonism. Ann Neurol. 2004;56:427-431.
10. Li Y, Tomiyama H, Sato K, et al. Clinicogenetic study of PINK1 mutations in autosomal recessive early-onset parkinsonism. Neurology. 2005;64:1955-1957.
11. Gibb WR, Lees AJ. A comparison of clinical and pathological features of young-and old-onset Parkinson's disease. Neurology. 1988;38:1402-1406.
12. Goetz CG, Fahn S, Martinez-Martin P, et al. New version of the UPDRS: development methods and working document for field testing [abstract]. Neurology. 2005;64(suppl 1):A394.
13. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
14. Sass H, Wittchen H-U, Zaudig M. Diagnostisches und statistisches Manual psychischer Störungen. Göttingen, Germany: Hogrefe; 1996.
15. Klein C, Djarmati A, Hedrich K, et al. Frequency of PINK1, parkin, and DJ-1 mutations in early-onset parkinsonism. Eur J Hum Genet. 2005;13:1086-1093.
16. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science. 1997;276:2045-2047.
17. Klein C, Pramstaller PP, Kis B, et al. Parkin deletions in a family with adult-onset, tremor-dominant parkinsonism: expanding the phenotype. Ann Neurol. 2000;48:65-71.
18. Pramstaller PP, Schlossmacher MG, Jacques TS, et al. Lewy body Parkinson's disease in a large pedigree with 77 parkin mutation carriers. Ann Neurol. 2005;58:411-422.
19. Uitti RJ, Baba Y, Whaley NR, Wszolek ZK, Putzke JD. Parkinson disease: handedness predicts asymmetry. Neurology. 2005;64:1925-1930.
20. Zadikoff C, Rogaeva E, Djarmati A, et al. Homozygous and heterozygous PINK1 mutations: considerations for diagnosis and care of Parkinson's disease patients [published online ahead of print March 17, 2006]. Mov Disord. doi:10.1002/mds.20854. Accessed May 4, 2006.
21. Klein C, Grünewald A, Hedrich K. Biologic effect of a PINK1 mutation: mRNA levels of the c.1366C>T (Gln456Stop) change [letter]. Neurology. 2006;66:1129-1130.
22. Healy DG, Abou-Sleiman PM, Gibson JM, et al. PINK1 (PARK6) associated Parkinson disease in Ireland. Neurology. 2004;63:1486-1488.
23. Rogaeva E, Johnson J, Lang AE, et al. Analysis of the PINK1 gene in a large cohort of cases with Parkinson disease. Arch Neurol. 2004;61:1898-1904.
24. Khan NL, Horta W, Eunson L, et al. Parkin disease in a Brazilian kindred: manifesting heterozygotes and clinical follow-up over 10 years. Mov Disord. 2005;20:479-484.
25. Lees AJ. When did Ray Kennedy's Parkinson's disease begin? Mov Disord. 1992;7:110-116.